Kura Oncology, Inc. (NASDAQ: KURA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT KURA ONCOLOGY, INC.

Kura Oncology, Inc. (NASDAQ: KURA)
Listen to this Section


$10.36
-0.0050 ( -0.05% ) 0.8K

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

Market Data


Open $10.36
Previous Close $10.36
Volume 0.8K
Market Cap $942.78M
Day Range $10.30 - $10.34
52 Week Range $5.45 - $12.49
Shares Outstanding 88.77M
Change % -0.05%
Net Change ▼ -0.0050
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2015
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -20,109.00

Date Type Amount Purchased Purchaser
2025-09-09 Buy 50000.00 WILSON TROY EDWARD
2025-08-14 Buy 36506.00 WILSON TROY EDWARD
2024-06-07 Sale -26000.00 Collins Helen Louise
2024-06-07 Sale -26000.00 Parks Diane L.
2024-06-07 Sale -26000.00 Szela Mary T
2024-06-07 Sale -26000.00 Hasnain Faheem
2024-05-20 Sale -2615.00 Bair Teresa Brophy

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 11 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 43 Jun 03, 2025

Latest News